Related Experiment Videos

Pulmonary diseases in children with severe combined immune deficiency and DiGeorge syndrome

J Deerojanawong1, A B Chang, P A Eng

  • 1Department of Thoracic Medicine, Royal Children's Hospital, Melbourne, Victoria, Australia.

Pediatric Pulmonology
|January 4, 1998
PubMed

Insights

Pulmonary disease is common in children with T-cell immunodeficiencies like severe combined immune deficiency (SCID) and DiGeorge syndrome. Early and late lung complications significantly contribute to illness and death in these patients.

Area of Science:

  • Pediatric Pulmonology
  • Immunology
  • Infectious Diseases

Background:

  • T-cell immunodeficiencies frequently present with or lead to pulmonary disease.
  • Severe combined immune deficiency (SCID) and DiGeorge syndrome are primary T-cell disorders with significant respiratory implications.

Purpose of the Study:

  • To investigate the prevalence and types of pulmonary disease in children with SCID and DiGeorge syndrome.
  • To identify common pathogens and complications associated with lung disease in these pediatric populations.

Main Methods:

  • Retrospective review of 15 children with SCID and 19 with DiGeorge syndrome.
  • Analysis of presenting features, causative organisms, and late pulmonary complications from 1981 to 1995.

Main Results:

  • Pulmonary disease was a common presenting feature (67%) in SCID, with Pneumocystis carinii pneumonia (PCP) and bacterial/viral infections being frequent. Late complications included lower respiratory tract infections and lymphointerstitial pneumonitis.
  • Pulmonary complications contributed to mortality in 5 of 9 SCID deaths. In DiGeorge syndrome, while not a primary presenting feature, pulmonary complications like recurrent infections and bronchomalacia were common.
  • Effective prophylaxis likely reduced late PCP occurrences in SCID.

Conclusions:

  • Pulmonary disease is a significant manifestation and complication in children with SCID and DiGeorge syndrome.
  • Early identification and management of lung infections and complications are crucial for improving outcomes in these immunocompromised children.
  • Pulmonary morbidity and mortality are substantial concerns in both SCID and DiGeorge syndrome.

Related Concept Videos